not tagged
cel-sci
['headneck', '$cvm']
#celscis phase 3 data presented at #esmo22 reported #neoadjuvantmultikine achieved groundbreaking #tumor response &amp; extended overall survival in locally advanced #headneckcancer #esmo22 $cvm 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.